Alpha Teknova (NASDAQ:TKNO – Get Rating) and Achieve Life Sciences (NASDAQ:ACHV – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership.
Profitability
This table compares Alpha Teknova and Achieve Life Sciences' net margins, return on equity and return on assets.
Get
Alpha Teknova alerts:
| Net Margins | Return on Equity | Return on Assets |
| Alpha Teknova | -86.67% | -16.09% | -12.24% |
| Achieve Life Sciences | N/A | -240.36% | -104.96% |
Valuation & Earnings
This table compares Alpha Teknova and Achieve Life Sciences' gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
| Alpha Teknova | $36.89 million | 4.64 | -$9.80 million | ($1.35) | -4.52 |
| Achieve Life Sciences | N/A | N/A | -$33.15 million | ($3.99) | -1.18 |
Alpha Teknova has higher revenue and earnings than Achieve Life Sciences. Alpha Teknova is trading at a lower price-to-earnings ratio than Achieve Life Sciences, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of recent ratings and price targets for Alpha Teknova and Achieve Life Sciences, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
| Alpha Teknova | 0 | 0 | 1 | 0 | 3.00 |
| Achieve Life Sciences | 0 | 0 | 2 | 0 | 3.00 |
Alpha Teknova currently has a consensus target price of $9.33, indicating a potential upside of 53.01%. Achieve Life Sciences has a consensus target price of $17.33, indicating a potential upside of 268.01%. Given Achieve Life Sciences' higher possible upside, analysts plainly believe Achieve Life Sciences is more favorable than Alpha Teknova.
Institutional and Insider Ownership
22.7% of Alpha Teknova shares are owned by institutional investors. Comparatively, 21.1% of Achieve Life Sciences shares are owned by institutional investors. 15.2% of Alpha Teknova shares are owned by insiders. Comparatively, 1.0% of Achieve Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Risk and Volatility
Alpha Teknova has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500. Comparatively, Achieve Life Sciences has a beta of 1.22, meaning that its share price is 22% more volatile than the S&P 500.
Summary
Alpha Teknova beats Achieve Life Sciences on 7 of the 12 factors compared between the two stocks.
About Alpha Teknova
(Get Rating)
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
About Achieve Life Sciences
(Get Rating)
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.
